Results 11 to 20 of about 207,267 (296)

Prediction of Viable CD34 Count in Harvested Product by Peripheral Blood Hematopoietic Progenitor Count of Automated Hematology Analyzer Undergoing Hematopoietic Stem Cell Transplantation

open access: yesJournal of Blood Medicine
Siew Lian Chong,1,* Asral Wirda Ahmad Asnawi,1,2,* Tengku Amatullah Madeehah Tengku Mohd,2,* Sen Mui Tan1,* 1Department of Hematology, Hospital Ampang, Ampang Jaya, Selangor, Malaysia; 2Faculty of Medicine and Health Sciences, Universiti ...
Chong SL   +3 more
doaj   +2 more sources

A simple model system enabling human CD34+ cells to undertake differentiation towards T cells [PDF]

open access: yes, 2013
Channelling the development of haematopoietic progenitor cells into T lymphocytes is dependent upon a series of extrinsic prompts whose temporal and spatial sequence is critical for a productive outcome.
B-Lynch Christopher   +11 more
core   +1 more source

Nilotinib concentration in cell lines and primary CD34+ chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters [PDF]

open access: yes, 2009
Imatinib mesylate and nilotinib are highly effective at eradicating the majority of chronic myeloid leukemia (CML) cells; however, neither agent induces apoptosis of primitive CML CD34<sup>+</sup> cells.
Holyoake, T.L.   +10 more
core   +1 more source

Milieu-adopted in vitro and in vivo differentiation of mesenchymal tissues derived from different adult human CD34-negative progenitor cell clones [PDF]

open access: yes, 2005
Adult mesenchymal stem cells with multilineage differentiation potentially exist in the bone marrow, but have also been isolated from the peripheral blood.
Moser, C.   +4 more
core   +1 more source

The effects of bone marrow stem and progenitor cell seeding on urinary bladder tissue regeneration

open access: yesScientific Reports, 2021
Complications associated with urinary bladder augmentation provide the motivation to delineate alternative bladder tissue regenerative engineering strategies.
Matthew I. Bury   +8 more
doaj   +1 more source

Effect of low level ionizing radiation on endothelial progenitor cells in therosclerotic patients with lower limb ischemia

open access: yesZagazig Journal of Pharmaceutical Sciences, 2013
Various studies had underlined the important role of bone marrow-derived endothelial progenitor cells (EPCS) in vasculogenesis and angiogenesis of ischemic tissue, but only a few studies had concentrated on the role of low doses of ionizing gamma ...
Hoda Mohammed   +3 more
doaj   +1 more source

Improved arteriogenesis with simultaneous skeletal muscle repair in ischemic tissue by SCL plus multipotent adult progenitor cell clones from peripheral blood [PDF]

open access: yes, 2004
Background: The CD34- murine stem cell line RM26 cloned from peripheral blood mononuclear cells has been shown to generate hematopoietic progeny in lethally irradiated animals.
Seliger, Christian   +15 more
core   +1 more source

Inhibition of MDR1 does not sensitize primitive chronic myeloid leukemia CD34+ cells to imatinib [PDF]

open access: yes, 2009
<p><b>Objective:</b> To investigate the interaction of imatinib mesylate (IM) with the clinically relevant adenosine triphosphate-binding cassette efflux transporter MDR1 (ABCB1) in cells from patients with chronic myeloid leukemia (CML)
Holyoake, T.L.   +4 more
core   +1 more source

Hepatocyte growth factor and carotid intima-media thickness in relation to circulating CD34-positive cell levels [PDF]

open access: yes, 2018
Hepatocyte growth factor (HGF) may act as a possible biochemical index for vascular damage, although evidence for the association between HGF and carotid intima-media thickness (CIMT) is limited. Since both HGF and circulating CD34-positive cells play an
Kawashiri, Shin-Ya   +23 more
core   +1 more source

Uptake of synthetic low density lipoprotein by leukemic stem cells — a potential stem cell targeted drug delivery strategy [PDF]

open access: yes, 2010
Chronic Myeloid Leukemia (CML) stem/progenitor cells, which over-express Bcr-Abl, respond to imatinib by a reversible block in proliferation without significant apoptosis.
Jørgensen, Heather G.   +25 more
core   +1 more source

Home - About - Disclaimer - Privacy